Hepatitis B (chronic) - adefovir dipivoxil and pegylated interferon alfa-2a (TA96) (partially updated by CG165)
Fast, easy summary view of NICE guidance on 'hepatitis b chronic'
This guidance has been partially updated by CG165 Hepatitis B (chronic)
Recommendation 1.1 has been incorporated into NICE clinical guideline 165 as recommendation 1.5.8:
Peginterferon alfa-2a is recommended as an option for the initial treatment of adults with chronic hepatitis B (HBeAg-positive or HBeAg-negative), within its licensed indications.
Recommendations 1.2, 1.3 and 1.4 have been replaced by recommendations 1.5.13, 1.5.14 and 1.5.15 in NICE clinical guideline 165.
Adefovir dipivoxil is no longer recommended for the treatment of chronic hepatitis B.
- TA96 Hepatitis B (chronic) - adefovir dipivoxil and pegylated interferon alfa-2a: guidance (web format)
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: hepatitis b chronic
- Hepatitis B (chronic) - adefovir dipivoxil and pegylated interferon alfa-2a: review decison - October 2011
- Hepatitis B (chronic) - adefovir dipivoxil and pegylated interferon alfa-2a: review proposal - July 2011
- Review decision: June 2009
- Review proposal: May 2009
- Review decision, October 2007
- Review proposal, July 2007
- Hepatitis B (chronic) - adefovir dipivoxil and pegylated interferon alfa-2a: assessment report
- People with chronic hepatitis B to benefit from guidance on new drugs and treatments
- Appendix A
- Appendix A - matrix of consultees and commentators
- Appendix 1: Proposal comment summary table
This page was last updated: 26 June 2013
Information for the public
Implementation tools and resources
- Hepatitis B (chronic) - adefovir dipivoxil and pegylated interferon alfa-2a: analysis of cost impact
- TA96 Drug treatment for chronic hepatitis B: slide set
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.